Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for ValenzaBio

    Client Virtual Booth

    VALENZABIO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ValenzaBio
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6701 Democracy Blvd Suite 300 Bethesda, Maryland 20817
    Telephone
    Telephone
    212 945 8929
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.valenzabiotech.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ACELYRIN Furthers Leadership Position Immunology with Acquisition of ValenzaBio
    ACELYRIN Furthers Leadership Position Immunology with Acquisition of ValenzaBio

    https://www.biospace.com/article/releases/acelyrin-inc-furthers-leadership-position-in-immunology-with-transformative-acquisition-of-valenzabio/?s=79

    BIOSPACE
    05 Jan 2023
    Share Share
    ProBioGen & ValenzaBio Enter Second Service Agreement
    ProBioGen & ValenzaBio Enter Second Service Agreement

    https://www.contractpharma.com/contents/view_breaking-news/2022-06-14/probiogen-valenzabio-enter-second-service-agreement/?widget=listSection

    CONTRACTPHARMA
    14 Jun 2022
    Share Share
    ValenzaBio Announces FDA Clearance of IND for VB421 in Thyroid Eye Disease
    ValenzaBio Announces FDA Clearance of IND for VB421 in Thyroid Eye Disease

    https://www.businesswire.com/news/home/20220331006007/en

    BUSINESSWIRE
    31 Mar 2022
    Share Share
    ValenzaBio, Novelty Nobility Announce Exclusive License Agreement
    ValenzaBio, Novelty Nobility Announce Exclusive License Agreement

    https://www.businesswire.com/news/home/20220215005384/en

    BUSINESSWIRE
    15 Feb 2022
    Share Share
    ValenzaBio, ProBioGen Enter Cell Line Pact
    ValenzaBio, ProBioGen Enter Cell Line Pact

    https://www.contractpharma.com/contents/view_breaking-news/2021-07-28/valenzabio-probiogen-enter-cell-line-pact/?widget=listSection

    CONTRACT PHARMA
    27 Jul 2021
    Share Share
    Lonza and ValenzaBio Enter Manufacturing Agreement to Rapidly Advance VB421
    Lonza and ValenzaBio Enter Manufacturing Agreement to Rapidly Advance VB421

    https://www.lonza.com/news/2021-06-18-15-00

    PRESS RELEASE
    18 Jun 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search